166 related articles for article (PubMed ID: 7678906)
1. Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.
Ashby J; Vogel EW; Tinwell H; Callander RD; Shuker DE
Mutat Res; 1993 Mar; 286(1):101-9. PubMed ID: 7678906
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity to the mouse bone marrow by the mouse germ cell mutagen N-propyl-N-nitrosourea.
Tinwell H; Yendle J; Ashby J
Mutat Res; 1996 Oct; 370(3-4):141-3. PubMed ID: 8917659
[TBL] [Abstract][Full Text] [Related]
3. Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.
Aydemir N; Sevim N; Celikler S; Vatan O; Bilaloglu R
Mutat Res; 2009; 679(1-2):1-5. PubMed ID: 19712749
[TBL] [Abstract][Full Text] [Related]
4. Genetic activity of the human carcinogen sulphur mustard towards Salmonella and the mouse bone marrow.
Ashby J; Tinwell H; Callander RD; Clare N
Mutat Res; 1991 May; 257(3):307-11. PubMed ID: 2014034
[TBL] [Abstract][Full Text] [Related]
5. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
6. Activity of the human carcinogen MeCCNU in the mouse bone marrow micronucleus assay.
Tinwell H; Ashby J
Environ Mol Mutagen; 1991; 17(3):152-4. PubMed ID: 2022193
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity testing of extracts of a Swedish moist oral snuff.
Jansson T; Romert L; Magnusson J; Jenssen D
Mutat Res; 1991 Oct; 261(2):101-15. PubMed ID: 1922153
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
[TBL] [Abstract][Full Text] [Related]
9. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chloral Hydrate (Cas No. 302-17-0) in B6C3F1 mice (Gavage Studies).
Natl Toxicol Program Tech Rep Ser; 2002 Feb; (502):1-197. PubMed ID: 11965861
[TBL] [Abstract][Full Text] [Related]
10. DNA damage and repair in somatic and germ cells in vivo.
Vogel EW; Natarajan AT
Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
[TBL] [Abstract][Full Text] [Related]
11. Clastogenicity to the mouse bone marrow of the mouse germ cell genotoxin streptozotocin.
Liegibel U; Tinwell H; Callander RD; Schmezer P; Ashby J
Mutagenesis; 1992 Nov; 7(6):471-4. PubMed ID: 1474923
[TBL] [Abstract][Full Text] [Related]
12. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice.
Wild D; Gocke E; Harnasch D; Kaiser G; King MT
Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347
[TBL] [Abstract][Full Text] [Related]
13. Genotoxicity testing of methyl tertiary-butyl ether (MTBE) in the Salmonella microsuspension assay and mouse bone marrow micronucleus test.
Kado NY; Kuzmicky PA; Loarca-PiƱa G; Moiz Mumtaz M
Mutat Res; 1998 Jan; 412(2):131-8. PubMed ID: 9580226
[TBL] [Abstract][Full Text] [Related]
14. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna.
Kirkland D; Marzin D
Mutat Res; 2003 Jun; 537(2):183-99. PubMed ID: 12787822
[TBL] [Abstract][Full Text] [Related]
16. [The genotoxicity and carcinogenic potential of gastrofenzin].
Mirkova E
Eksp Med Morfol; 1994; 32(3-4):57-68. PubMed ID: 8857033
[TBL] [Abstract][Full Text] [Related]
17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
18. Mutagens that are not carcinogens: faulty theory or faulty tests?
Zeiger E
Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
[TBL] [Abstract][Full Text] [Related]
19. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
Gold LS; Slone TH; Stern BR; Bernstein L
Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma.
Hayes MT; Bartley J; Parsons PG
Melanoma Res; 1998 Feb; 8(1):67-75. PubMed ID: 9508380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]